MarketsStocksTRABI
TR

Transgene Biotek Ltd.

NSE: TRABIBSE: 526139Healthcare
Download Research Report7-page PDF
3.13
+0.64%
NSE · auto-updates while market open
Mkt Cap
₹23 Cr
P / E
-
P / B
2.8
ROE
-17.9%
52W High
₹5.26
52W Low
₹1.83
Key Metrics
Market Cap
₹23 Cr
P / E
-
P / B
2.75
EV / EBITDA
-
ROCE
-2.4%
ROE
-17.9%
Debt / Equity
2.05
Book Value
₹1.11
EPS
-
Div Yield
0.0%
Face Value
-
Promoter Holding
23.6%
Revenue · ₹ Cr
0
FY22
0
FY24
0
FY25
0
FY26
Net Profit · ₹ Cr
-10
-1
-1
-2
FY22FY24FY25FY26
EPS · ₹ per share
₹0.1
₹-1.4
FY22FY24
Q1 2026 snapshot
Sales
₹0 Cr
Operating profit
-
OPM
-
Net profit
₹-0 Cr
EPS
-
Scorecard · 7 axes
Quality
Bad
18/100
Valuation
-
Growth
-
Profitability
Bad
-10.1%
Performance
Bad
-20.7%
Entry Point
Strong
60%
Red Flags
Avg
1 flag
Shareholding Pattern
23.6%Promoter
Promoter23.6%
Public76.4%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue0.120.120.050.050.050.2
Net Profit-0.088-0.713-0.434-0.388-0.374-0.457
NPM %-73.3%-594.3%-867.4%-776.8%-747.4%-228.5%
AlertPre-trade